Corline Biomedical AB
SSE:CLBIO.ST
13.8 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -1.788 | 2.329 | -6.909 | -7.287 | -9.54 | -6.792 | -7.809 | -5.22 | -5.676 | -2.512 | -2.488 | -0.911 |
| Depreciation & Amortization
| 0.097 | 0.056 | 0.031 | 0.014 | 0.009 | 0 | 0.001 | 0.001 | 0.028 | 0.034 | 0.027 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 2.598 | -8.837 | 2.056 | 2.207 | -4.308 | 2.689 | 2.831 | -1.964 | 1.586 | 0.159 | -0.299 | 0 |
| Accounts Receivables
| 3.003 | -6.604 | -1.131 | 0.389 | -0.788 | 0.238 | -0.141 | -0.748 | -0.183 | 0.135 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.37 | 2.382 | 0.518 | 0.623 | -0.943 | -1.474 | 2.467 | -0.833 | 1.462 | 0 | 0 | 0 |
| Other Working Capital
| -0.405 | -4.615 | 2.669 | 1.195 | -2.577 | 3.925 | 0.504 | -0.383 | 0.307 | -0.083 | 0 | 0 |
| Other Non Cash Items
| -0.021 | 4.334 | -0.013 | -0.984 | 1.749 | -0.001 | -0.001 | -0.028 | -0.141 | -0.01 | -0.071 | 0.911 |
| Operating Cash Flow
| 0.886 | -6.452 | -4.835 | -5.066 | -13.839 | -4.104 | -4.978 | -7.211 | -4.231 | -2.319 | -2.759 | 0 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -10.621 | -8.999 | -9.617 | -8.8 | -4.844 | -0.937 | -5.02 | -8.536 | -4.844 | -2.718 | -3.085 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -10.489 | -8.845 | -9.421 | -8.75 | -4.844 | -0.891 | -5.02 | -0.001 | -4.844 | -2.685 | 0 | 0 |
| Investing Cash Flow
| -10.621 | -8.999 | -9.561 | -8.8 | -4.844 | -0.937 | -5.02 | -8.537 | -4.844 | -2.718 | -3.085 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.237 | 0 | 0 | 0 |
| Common Stock Issued
| 0.537 | 0.026 | 50.634 | 0 | 13.95 | 15.829 | 14.99 | 22.744 | 11.061 | 0 | 9.9 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.537 | 0.026 | -3.508 | 0 | -0.054 | 15.829 | 14.99 | 22.744 | 1.237 | 5.503 | -5.216 | 0 |
| Financing Cash Flow
| 0.537 | 0.026 | 47.126 | 0 | 13.896 | 15.829 | 14.99 | 22.744 | 12.298 | 5.503 | 4.684 | 0 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -9.198 | -15.425 | 32.73 | -13.866 | -4.787 | 10.788 | 4.992 | 6.996 | 3.223 | 0.466 | -1.161 | 0 |
| Cash At End Of Period
| 17.012 | 26.21 | 41.635 | 8.991 | 22.857 | 27.644 | 16.856 | 11.864 | 4.868 | 1.645 | 1.179 | 0 |